News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Precision BioSciences Sues Cellectis BioResearch for Patent Infringement



10/6/2011 9:43:51 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., the world leader in rational genome engineering, today announced that it has filed a lawsuit against Cellectis SA and its affiliates Cellectis bioresearch and Cellectis bioresearch Inc. in the U.S. District Court for the Eastern District of North Carolina. The lawsuit seeks a ruling that Cellectis’ manufacture, use and sale of certain engineered meganucleases infringe U.S. Patent No. 8,021,867, a recently-issued patent related to Precision’s Directed Nuclease EditorTM (DNE) meganuclease technology. The lawsuit requests monetary damages as well as a permanent injunction preventing Cellectis from making, using, selling, offering for sale, or importing infringing engineered meganucleases in the United States.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES